Speaker Profile
Ph.D., Chief Scientific Officer, Solve M.E.
Biography
Tim leads Solve M.E.s data, AI, and research strategy to advance precision medicine for MECFS, Long COVID, and other post-infection diseases. He is an author and reviewer for the JCO Clinical Cancer Informatics and a member of the NINDS MECFS Biospecimen Resource Access Committee. Previously, Tim oversaw research funding at both the American Society for Radiation Oncology and the NIH. He has been recognized by awards such as the NIH Directors Award, NCATS Directors Award, NIAID Merit Award, the U.S. Department of State Embassy Science Fellowship, and the American Association for the Advancement of Science (AAAS) Science and Technology Policy Fellowship.
Talk
RWD to Advance Precision Medicine for Post-Acute Infection Syndromes.
After the concept and architecture of Solve M.E.'s RWD strategy and platform are introduced, case studies will demonstrate how RWD advanced patient subtyping, personalized analytics, hypothesis generation, and clinical trial recruitment. Future plans to leverage AIML, digital biomarkers, and digital twin to further catalyze precision medicine research will also be discussed.
AI and Data Sciences Showcase:
Solve M.E.
The Solve ME/CFS Initiative (Solve M.E.) is a non-profit organization that serves as a catalyst for critical research into diagnostics, treatments, and cures for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long Covid and other post-infection diseases.
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2024 AI Company Showcase will provide a 15-minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
